Kristjansdottir, H.L. http://orcid.org/0000-0002-0959-0807
Mellström, D.
Johansson, P.
Karlsson, M.
Vandenput, L.
Lorentzon, M.
Herlitz, H.
Ohlsson, C.
Lerner, U.H.
Lewerin, C.
Funding for this research was provided by:
The Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG872941)
Göteborgs Läkaresällskap (GLS-880451)
Sahlgrenska Universitetssjukhuset (SU890891)
Article History
Received: 3 September 2020
Accepted: 25 November 2020
First Online: 11 December 2020
Compliance with ethical standards
:
: Mattias Lorentzon has received lecture or consulting fees from Amgen, Lilly, Meda, UCB Pharma, Renapharma, Radius Health and Consilient Health, all outside the submitted work.